Table 1.
Reported case of acute hepatitis after mRNA vaccine.
| Age (years), sex | Type of vaccine, number of doses | Time to symptoms onset | Autoantibodies | Concomitant autoimmune diseases/drugs | IgG (g/l) |
Treatment | Outcome | Reference |
|---|---|---|---|---|---|---|---|---|
| 35, F | BNT162b2, 1 dose | 1 week | ANA + hom, AMA-, ASMA-, anti-LKM-, ANCA- | Post-partum state/none | 10.8 | Prednisone 20 mg | Improved | Bril et al. [8] |
| 41, F | mRNA-1273, 2 doses | 1 week after 2nd dose | ANA + pattern not reported, SMA+, anti-SLA+, anti-LC1+ | None/substitutive hormonal therapy | 20.8 | Prednisone 1 mg/kg | Improved | Londono et al. [7] |
| 80, F | BNT162b2, 2 doses |
1 week after 2nd dose | ANA + speckled; AMA-, anti-LKM-, ASMA- |
Hashimoto, glomerulonephritis/ Pravastatin |
35 | Prednisone 1 mg/kg |
Improved | Rocco et al. [9] |
| 56, F | mRNA-1273, 1 dose | 5 weeks | ANA+, SMA+ Patterns not reported |
None/ Rosuvastatin |
32.6 | Budesonide | Improved | Tan et al. [10] |